US Patent 7157447 Bicyclic heterocycles as HIV integrase inhibitors

Patent 7157447 was granted and assigned to Bristol-Myers Squibb on January, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

All edits

Edits on 6 Sep, 2023

"Add patent inventor(s)"

Golden AI

edited on 6 Sep, 2023

Edits made to:

Infobox (+12 properties)

Infobox

Patent Inventor Names

B. Narasimhulu Naidu0

Carl Ouellet0

Francis Beaulieu0

Jacques Banville0

John D. Matiskella0

Margaret E. Sorenson0

Mark R. Krystal0

Michael A. Walker0

Roger Remillard0

Serge Plamondon0

Timothy P. Connolly0

Yasutsugu Ueda0

Edits on 31 Aug, 2023

"Add patent abstract"

Golden AI

edited on 31 Aug, 2023

Edits made to:

Article (+352 characters)

Article

Patent abstract

The invention encompasses a series bicyclic pyrimidinone compounds of Formula I which inhibit HIV integrase and prevent viral integration into human DNA. This action makes the compounds useful for treating HIV infection and AIDS. The invention also encompasses pharmaceutical compositions and methods for treating those infected with HIV

Edits on 23 May, 2023

"Remove website redirecting to Patent Public Search front page"

Golden AI

edited on 23 May, 2023

Edits made to:

Infobox (-1 properties)

Infobox

Official Website

https://pdfpiw.uspto.gov/.piw?Docid=071574470

Edits on 21 May, 2023

"Remove leading 0 from patent number"

Golden AI